360 related articles for article (PubMed ID: 9421348)
1. Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression.
Leinonen E; Lepola U; Koponen H; Mehtonen OP; Rimon R
Acta Psychiatr Scand; 1997 Dec; 96(6):497-504. PubMed ID: 9421348
[TBL] [Abstract][Full Text] [Related]
2. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
Olié JP; Gourion D; Montagne A; Rostin M; Poirier MF
Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
[TBL] [Abstract][Full Text] [Related]
3. A double-blind six months comparative study of milnacipran and clomipramine in major depressive disorder.
Steen A; Den Boer JA
Int Clin Psychopharmacol; 1997 Sep; 12(5):269-81. PubMed ID: 9466161
[TBL] [Abstract][Full Text] [Related]
4. Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency.
Isaac MT; Isaac MB; Gallo F; Tournoux A
Hum Psychopharmacol; 2003 Dec; 18(8):595-601. PubMed ID: 14696018
[TBL] [Abstract][Full Text] [Related]
5. Controlled comparison of milnacipran and fluoxetine in major depression.
Ansseau M; Papart P; Troisfontaines B; Bartholomé F; Bataille M; Charles G; Schittecatte M; Darimont P; Devoitille JM; De Wilde J
Psychopharmacology (Berl); 1994 Feb; 114(1):131-7. PubMed ID: 7846195
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group.
Ravindran AV; Judge R; Hunter BN; Bray J; Morton NH
J Clin Psychiatry; 1997 Mar; 58(3):112-8. PubMed ID: 9108813
[TBL] [Abstract][Full Text] [Related]
7. Interest of a loading dose of milnacipran in endogenous depressive inpatients. Comparison with the standard regimen and with fluvoxamine.
Ansseau M; von Frenckell R; Gérard MA; Mertens C; De Wilde J; Botte L; Devoitille JM; Evrard JL; De Nayer A; Darimont P
Eur Neuropsychopharmacol; 1991 May; 1(2):113-21. PubMed ID: 1821700
[TBL] [Abstract][Full Text] [Related]
8. Comparison of efficacy and safety of milnacipran and fluoxetine in Korean patients with major depression.
Lee MS; Ham BJ; Kee BS; Kim JB; Yeon BK; Oh KS; Oh BH; Lee C; Jung HY; Chee IS; Choe BM; Paik IH
Curr Med Res Opin; 2005 Sep; 21(9):1369-75. PubMed ID: 16197655
[TBL] [Abstract][Full Text] [Related]
9. Fluvoxamine and clomipramine in depressed hospitalised patients: results from a randomised, double-blind study.
Ottevanger EA
Encephale; 1995; 21(4):317-21. PubMed ID: 7588171
[TBL] [Abstract][Full Text] [Related]
10. Fluvoxamine as effective as clomipramine against symptoms of severe depression: results from a multicentre, double-blind study.
Zohar J; Keegstra H; Barrelet L
Hum Psychopharmacol; 2003 Mar; 18(2):113-9. PubMed ID: 12590404
[TBL] [Abstract][Full Text] [Related]
11. Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results.
Kasper S; Pletan Y; Solles A; Tournoux A
Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():35-9. PubMed ID: 8923125
[TBL] [Abstract][Full Text] [Related]
12. A double-blind comparison of the efficacy and safety of milnacipran and fluoxetine in depressed inpatients.
Guelfi JD; Ansseau M; Corruble E; Samuelian JC; Tonelli I; Tournoux A; Plétan Y
Int Clin Psychopharmacol; 1998 May; 13(3):121-8. PubMed ID: 9690979
[TBL] [Abstract][Full Text] [Related]
13. Controlled comparison of two doses of milnacipran (F 2207) and amitriptyline in major depressive inpatients.
Ansseau M; von Frenckell R; Mertens C; de Wilde J; Botte L; Devoitille JM; Evrard JL; De Nayer A; Darimont P; Dejaiffe G
Psychopharmacology (Berl); 1989; 98(2):163-8. PubMed ID: 2569214
[TBL] [Abstract][Full Text] [Related]
14. Milnacipran. A review of its use in depression.
Spencer CM; Wilde MI
Drugs; 1998 Sep; 56(3):405-27. PubMed ID: 9777315
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant efficacy and tolerability of milnacipran, a dual serotonin and noradrenaline reuptake inhibitor: a comparison with fluvoxamine.
Clerc G;
Int Clin Psychopharmacol; 2001 May; 16(3):145-51. PubMed ID: 11354236
[TBL] [Abstract][Full Text] [Related]
16. A randomised, double-blind comparison of milnacipran and imipramine in the treatment of depression.
Van Amerongen AP; Ferrey G; Tournoux A
J Affect Disord; 2002 Oct; 72(1):21-31. PubMed ID: 12204314
[TBL] [Abstract][Full Text] [Related]
17. Moclobemide versus clomipramine in depressed patients in general practice. A randomized, double-blind, parallel, multicenter study.
Kragh-Sørensen P; Müller B; Andersen JV; Buch D; Stage KB
J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):24S-30S. PubMed ID: 7593726
[TBL] [Abstract][Full Text] [Related]
18. Response rate obtained using milnacipran depending on the severity of depression in the treatment of major depressive patients.
Sugawara Y; Higuchi H; Yoshida K; Takahashi H; Kamata M; Naito S; Sato K; Shimizu T
Clin Neuropharmacol; 2006; 29(1):6-9. PubMed ID: 16518126
[TBL] [Abstract][Full Text] [Related]
19. Multicenter double-blind randomized parallel-group clinical trial of efficacy of the combination clomipramine (150 mg/day) plus lithium carbonate (750 mg/day) versus clomipramine (150 mg/day) plus placebo in the treatment of unipolar major depression.
Januel D; Poirier MF; D'alche-Biree F; Dib M; Olié JP
J Affect Disord; 2003 Sep; 76(1-3):191-200. PubMed ID: 12943949
[TBL] [Abstract][Full Text] [Related]
20. A double-blind study of the efficacy and safety of sertraline and clomipramine in outpatients with severe major depression.
Lépine JP; Goger J; Blashko C; Probst C; Moles MF; Kosolowski J; Scharfetter B; Lane RM
Int Clin Psychopharmacol; 2000 Sep; 15(5):263-71. PubMed ID: 10993128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
